Gross margin in the fourth quarter was 16.9%, an improvement of 390 basis points over prior year as a result of higher-margin sales from our Global Products segment, driven by continuing PPE demand as well as an improved operating efficiency.
This represents 8% growth and was driven by greater sales of PPE across both segments as well as growth in sales in our home healthcare business line and stabilization of the Medical Distribution business.
Eight, we generated operating cash flow of $71 million as a result of the increased earnings and working capital improvements.